AZTA vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AZTA

42.8
AI Score
VS
AZTA Wins

XRAY

41.8
AI Score

Investment Advisor Scores

AZTA

43score
Recommendation
HOLD

XRAY

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AZTA XRAY Winner
Revenue 454.62M 2.61B XRAY
Net Income -173.77M 25.00M XRAY
Gross Margin 43.6% 52.1% XRAY
Net Margin -38.2% 1.0% XRAY
Operating Income -177.21M 84.00M XRAY
ROE -11.5% 1.8% XRAY
ROA -9.3% 0.5% XRAY
Total Assets 1.88B 5.19B XRAY
Cash 189.65M 195.00M XRAY
Current Ratio 2.50 1.63 AZTA

Relative Price Performance (Last 90 Days)

AZTA 1M: +18.0% · 3M: +31.4% XRAY 1M: +9.5% · 3M: -20.3%

Current Technical Phase

AZTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.2% over 20 days), RSI 59

RSI (14): 59.1 · Price: $43.86

XRAY

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.3%) with fading momentum, RSI 46

RSI (14): 45.9 · Price: $9.24

Fundamentals Snapshot

Metric AZTA XRAY
Market Cap — —
Forward P/E 83.4 7.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% -0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.0% 0.0%
EPS -2.47 -0.61
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, AZTA is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.